Published in Int J Mol Med on May 17, 2016
Naïve helper T cells with high CD5 expression have increased calcium signaling. PLoS One (2017) 0.75
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55
Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J Exp Med (1985) 5.62
CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med (1998) 3.82
A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science (1995) 2.84
A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity (1997) 2.30
The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J Immunol (1985) 2.13
Development and physiology of Ly-1 B and its human homolog, Leu-1 B. Immunol Rev (1986) 2.12
Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med (1993) 1.95
Molecular events mediating T cell activation. Adv Immunol (1990) 1.85
CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science (1996) 1.84
Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc Natl Acad Sci U S A (1992) 1.83
T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. Immunity (2013) 1.58
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood (2015) 1.53
SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem (1999) 1.48
Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol (1997) 1.41
CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol (1999) 1.37
Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med (1996) 1.34
CD5 antibodies increase intracellular ionized calcium concentration in T cells. J Immunol (1987) 1.24
Several different cell surface molecules control negative selection of medullary thymocytes. J Exp Med (1999) 1.22
Negative regulation of CD4 lineage development and responses by CD5. J Immunol (1999) 1.20
The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev (2011) 1.19
TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1. J Immunol (1999) 1.13
Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism. Immunology (1993) 1.10
Multiple mechanisms of immune suppression by B lymphocytes. Mol Med (2012) 1.08
Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol (1999) 1.06
Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol (1991) 1.05
Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol (1992) 1.03
Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice. Blood (2005) 1.01
Differential effects of zeta and eta transgenes on early alpha/beta T cell development. J Exp Med (1994) 1.00
Chronic exposure to low levels of antigen in the periphery causes reversible functional impairment correlating with changes in CD5 levels in monoclonal CD8 T cells. J Immunol (2003) 0.99
Functional competency of T cell antigen receptors in human thymus. J Immunol (1987) 0.97
Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J Immunol (1999) 0.97
Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. J Proteome Res (2010) 0.96
Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes. Eur J Immunol (1992) 0.95
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia (2011) 0.94
CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte. Autoimmun Rev (2012) 0.94
B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms. Exp Cell Res (2003) 0.93
CD5, an important regulator of lymphocyte selection and immune tolerance. Immunol Res (2002) 0.92
Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. Int Immunol (2000) 0.92
The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem (2000) 0.91
Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem (1997) 0.87
Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5. Eur J Immunol (1997) 0.86
CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells. J Immunol (1999) 0.83
Thymocyte activation induces the association of the proto-oncoprotein c-cbl and ras GTPase-activating protein with CD5. Eur J Immunol (1998) 0.83
Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt/survivin pathway and inhibition of caspase-3 activity. J Pharmacol Exp Ther (2008) 0.83
Cutting edge: thymic selection and autoreactivity are regulated by multiple coreceptors involved in T cell activation. J Immunol (1999) 0.82
Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J Immunol (1999) 0.81
CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis. J Immunol (2014) 0.81
A potential role for B cells in suppressed immune responses in cord blood transplant recipients. Bone Marrow Transplant (2012) 0.81
The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses. Autophagy (2015) 0.79
CD5 and other superantigens may select and maintain rabbit self-renewing B-lymphocytes and human B-CLL cells. Curr Top Microbiol Immunol (2000) 0.79
Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses. PLoS One (2014) 0.78
Mechanisms of transmembrane signalling in human T cell activation. Mol Cell Biochem (1990) 0.78
Determination of the tyrosine phosphorylation sites in the T cell transmembrane glycoprotein CD5. Int Immunol (2001) 0.78